In both cohorts, mpMRI-derived tumor apparent diffusion coefficient (ADC) values and tumor volumes, as well as serum prostate-specific antigen (PSA) measurements, were similar between BCR-negative and BCR-positive patients (Fig. 1B and Table 1). Here, BCR is linked to neoplasm.